mortality/aging
• slightly fewer than expected mice survive to weaning
|
behavior/neurological
N |
• mice exhibit normal behavior including pain sensitivity, motor function, anxiety response, behaviors in the y-maze, alternation task and in cued and contextual fear conditioning
|
• PTZ-treated mice exhibit delayed onset and lower frequency of clonic and tonic seizures, but an increase in propensity for myoclonic jerks, compared with wild-type mice
• PTZ-treated mice exhibit more single spikes than wild-type mice and increased frequency and total duration of absence-like seizures in the frontal cortex
|
• mice exhibit protection from nicotine-clonic seizures compared with wild-type mice
|
• decreased distance spent in target quadrant of a Morris water maze
|
• when reintroduced into home cages
• however, mice do not exhibit an increase in restrain-induced corticosterone levels
|
• baseline
|
• slightly during habituation
• however, activity following challenge with amphetamine or PCP is normal
|
• in the maximal electroshock seizure threshold assay, mice exhibit strong protection from electrically-induced tonic seizures compared with wild-type mice
|
nervous system
N |
• mice exhibit normal brain weight and morphology with normal amphetamine- or PCP-disrupted prepulse inhibition
|
• PTZ-treated mice exhibit delayed onset and lower frequency of clonic and tonic seizures, but an increase in propensity for myoclonic jerks, compared with wild-type mice
• PTZ-treated mice exhibit more single spikes than wild-type mice and increased frequency and total duration of absence-like seizures in the frontal cortex
|
• mice exhibit protection from nicotine-clonic seizures compared with wild-type mice
|
• in the maximal electroshock seizure threshold assay, mice exhibit strong protection from electrically-induced tonic seizures compared with wild-type mice
|
growth/size/body
• beginning at 6 to 7 weeks of age as mice move into puberty
|
hearing/vestibular/ear
• reduced loudness dependence auditory evoked potential (LDAEP) in parietal and frontal cortex, but not the hippocampus
• reduced N1 and P2 AEP amplitudes in response to the first and second stimuli in the parietal cortex using the auditory double-click paradigm
• auditory stimulation (40 Hz) failed to induce an increase in gamma power in the parietal cortex, frontal cortex and hippocampus unlike in wild-type mice with a reduction in peak theta frequency in the hippocampus and prelimbic cortex
• however, mice exhibit normal AEP gating ratios and increase in gamma power in the prelimbic cortex
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
chromosome 15q13.3 microdeletion syndrome | DOID:0060394 |
OMIM:612001 |
J:260165 |